Correlation Between Guidewire Software, and CRISPR Therapeutics
Can any of the company-specific risk be diversified away by investing in both Guidewire Software, and CRISPR Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Guidewire Software, and CRISPR Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Guidewire Software, and CRISPR Therapeutics AG, you can compare the effects of market volatilities on Guidewire Software, and CRISPR Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Guidewire Software, with a short position of CRISPR Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Guidewire Software, and CRISPR Therapeutics.
Diversification Opportunities for Guidewire Software, and CRISPR Therapeutics
0.6 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Guidewire and CRISPR is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Guidewire Software, and CRISPR Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CRISPR Therapeutics and Guidewire Software, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Guidewire Software, are associated (or correlated) with CRISPR Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CRISPR Therapeutics has no effect on the direction of Guidewire Software, i.e., Guidewire Software, and CRISPR Therapeutics go up and down completely randomly.
Pair Corralation between Guidewire Software, and CRISPR Therapeutics
Assuming the 90 days trading horizon Guidewire Software, is expected to generate 0.34 times more return on investment than CRISPR Therapeutics. However, Guidewire Software, is 2.95 times less risky than CRISPR Therapeutics. It trades about 0.35 of its potential returns per unit of risk. CRISPR Therapeutics AG is currently generating about 0.04 per unit of risk. If you would invest 8,688 in Guidewire Software, on October 30, 2024 and sell it today you would earn a total of 744.00 from holding Guidewire Software, or generate 8.56% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 90.0% |
Values | Daily Returns |
Guidewire Software, vs. CRISPR Therapeutics AG
Performance |
Timeline |
Guidewire Software, |
CRISPR Therapeutics |
Guidewire Software, and CRISPR Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Guidewire Software, and CRISPR Therapeutics
The main advantage of trading using opposite Guidewire Software, and CRISPR Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Guidewire Software, position performs unexpectedly, CRISPR Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CRISPR Therapeutics will offset losses from the drop in CRISPR Therapeutics' long position.Guidewire Software, vs. Ameriprise Financial | Guidewire Software, vs. Jefferies Financial Group | Guidewire Software, vs. Mitsubishi UFJ Financial | Guidewire Software, vs. Verizon Communications |
CRISPR Therapeutics vs. Broadridge Financial Solutions, | CRISPR Therapeutics vs. Hospital Mater Dei | CRISPR Therapeutics vs. Elevance Health, | CRISPR Therapeutics vs. Zoom Video Communications |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |